Is Pazopanib immunotherapy?

Pazopanib is not an immunotherapy drug. It is a targeted drug therapy used to treat cancer. Pazopanib/Pazopanib is a tyrosine kinase inhibitor and vascular endothelial growth factor receptor inhibitor used to treat advanced renal cell carcinoma (RCC) (kidney cancer) and soft tissue sarcoma in adults.

The most common adverse reactions (≥ 20%) in patients with RCC are diarrhea, hypertension, hair color changes (depigmentation), nausea, anorexia, and vomiting. The most common adverse reactions (≥ 20%) in STS patients are fatigue, diarrhea, nausea, weight loss, hypertension, decreased appetite, vomiting, tumor pain, hair color changes, musculoskeletal pain, headache, dysgeusia, dyspnea and skin hypopigmentation.

Avoid coadministration of potent cyp3a 4inhibitors by using alternative coadministrations with no inhibitory CYP3A4potential or minimal potential to inhibit CYP3A4. If coadministration of a strong CYP3A4 inhibitor is necessary, reduce the dose of pazopanib tablets to 400 mg. Avoid concomitant use of strong CYP3A4 inducers by using alternative concomitant medications with no or minimal enzyme induction potential. Pazopanib tablets are not recommended for use in patients who cannot avoid long-term use of strong CYP3A4 inducers. Avoid concurrent use of acid-reducing agents. If concomitant use of acid-reducing agents cannot be avoided, consider using short-acting antacids instead of proton pump inhibitors (PPIs) and H2 receptor antagonists. Separate the administration of short-acting antacids and pazopanib tablets by several hours. There are generic drugs in Bangladesh, and the retail price of Bangladesh Yaopin International Pharmaceuticals is about 200mg 30 tablets 600 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.